Gaurang Nandkishor Vaidya

Abstract 4143638: Donation After Circulatory Death in Pediatric Heart Transplant Recipients: A Lost Opportunity for Donor Pool Expansion

Anuja Shikhare, Gaurang Nandkishor Vaidya, Liliam Aquino, Mark W. Cocalis et autres

Background: Donation after circulatory death (DCD) is underutilized in pediatric heart transplant (HTx). Methods: UNOS database was analyzed for HTx with reported DCD donors (1/2020-4/2024). Data is reported as median (interquartile range). Multiorgan and retransplant recipients were excluded from outcome analysis. Results: …

us (code pays fourni par la source)

Abstract 4145503: The Trifecta of Female Gender, LVAD and Sensitization: A Case for Higher Priority Listing for Heart Transplant

Gaurang Nandkishor Vaidya, Richard-Tien Ha, Sumanth Kidambi, Erna O. Nishime et autres

Background: Highly sensitized recipients are expected to have higher wait-time for heart transplant, however, their sensitization status does not grant them higher priority. Methods: UNOS database was analyzed for adult heart transplant recipients from Oct 2018 to April 2024 with reported calculated …

us (code pays fourni par la source)

Using electronic medical records to identify patients at risk for underlying cardiac amyloidosis

Michael A. Pascoe, Andrew Kolodziej, Emma J. Birks, Gaurang Nandkishor Vaidya

us (code pays fourni par la source)

Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy

AARON B. HESSELSON, Gaurang Nandkishor Vaidya, Andrew Kolodziej

Cardiac contractility modulation (CCM) can be a therapeutic aid in class III chronic systolic congestive heart failure, not indicated for biventricular pacing, and with left ventricular ejection fraction (LVEF) 25% to 45%.1 Recent observational data by Fastner and colleagues2 suggest a greater …

us (code pays fourni par la source)

COMPARISON OF DONATION TECHNIQUES IN THE US WITH A FOCUS ON NORMOTHERMIC REGIONAL PERFUSION

Gaurang Nandkishor Vaidya, Aly Elezaby, Richard V. Ha, Erna O. Nishime et autres

us (code pays fourni par la source)

Heart and Kidney Transplantation in Hereditary ATTR Amyloidosis and Smoldering Myeloma: A Multidisciplinary Approach

Gaurang Nandkishor Vaidya, Andrew Kolodziej, Talal S. Alnabelsi, Imo Ebong et autres

us (code pays fourni par la source)

Outcomes with Normothermic Regional Perfusion: Comparison with Core-Cooling During DCD Heart Transplantation

Gaurang Nandkishor Vaidya, Aly Elezaby, Richard D. Ha, Erna Obenza Nishime et autres

us (code pays fourni par la source)

Sex differences in heart transplantation - analysis of the national inpatient sample 2012-2019

Nakeya Dewaswala, Huzefa M. Bhopalwala, Abdul Mannan Khan Minhas, Khadija Amanullah et autres

us (code pays fourni par la source)

Preliminary Results In Genetic Cardiomyopathy With Significant Systolic Heart Failure Treated With Cardiac Contractility Modulation: A Single-Center Experience

AARON B. HESSELSON, Kristin Ellison, Karam F. Ayoub, Andrew Kolodziej et autres

us (code pays fourni par la source)

Abstract 16203: A Case for Cardiomems Use in Cardiac Amyloidosis to Prevent Hospitalization

Michael Pascoe, Andrew Kolodziej, Mindy S. Thompson, Andrew T. Yackzan et autres

Background: Patients with cardiac amyloidosis (CA) have recurrent hospital admissions for heart failure (CHF). However, CardioMEMS placement is still considered ‘investigational’ by various insurance payers, requiring peer-to-peer review for approval. Landmark CardioMEMS trials did not identify CA patients in their cohort, so …

us (code pays fourni par la source)

The Multidisciplinary Recipient Selection Process (Adult and Pediatric): Inclusion and Exclusion Criteria

Gaurang Nandkishor Vaidya, JON A. KOBASHIGAWA

This chapter focuses on various inclusion and exclusion criteria for successful selection of transplant recipients. The cardiomyopathies are a heterogenous group characterized by mechanical or electrical dysfunction of the heart resulting in ventricular hypertrophy or dilatation. The most common diagnosis prior to …

us (code pays fourni par la source)

Covid‐19 positive donor utilization for heart transplantation: The new frontier for donor pool expansion

Gaurang Nandkishor Vaidya, Paul Anaya, Maya T. Ignaszewski, Andrew Kolodziej et autres

BACKGROUND: Hearts from COVID-19 positive donors (CPD) are being utilized for heart transplantation by some centers; however, this is in the setting of the lack of guidelines or robust evidence. The paucity of evidence is reflected in the recent Organ Procurement and …

us (code pays fourni par la source)